Synthomer

Synthomer produces and supplies acrylic acids and acrylic esters, serving a wide range of industrial applications. The company benefits from an integrated product portfolio combined with a highly flexible and efficient production set-up, enabling the dynamic optimization of product mix and margins. Synthomer generated revenues of approximately EUR 110 million and employs around 300 people. The business provides a strong basis for further development, supported by substantial operational and commercial optimization potential and a clear path towards profitable growth.

Strategy

The acquisition of Synthomer represents a strategic platform investment for Mutares’ Chemicals & Materials segment. The transaction is fully aligned with Mutares’ strategy of acquiring businesses with significant operational improvement potential from special situations and provides a clear path towards substantial value creation. The main focus after completion of the extensive carve-out lies on optimizing the product portfolio and accelerating innovation toward higher-margin bio-acrylic products. Further, the company will profit from improved processes and cost stabilisation measures across the functions.